FeesSafety
Pluang+

FDA accepts Celcuity's sNDA for REVTORPYK to treat advanced HR+/HER2- breast cancer with PIK3CA mutation

Market News
09 Nov 2026, 15:30 WIB
GlobeNewsWire
View Source
Bullish
FDA accepts Celcuity's sNDA for REVTORPYK to treat advanced HR+/HER2- breast cancer with PIK3CA mutation

Celcuity Inc. announced the FDA has accepted its supplemental New Drug Application for REVTORPYK (gedatolisib) to treat hormone receptor positive, HER2-negative, locally advanced or metastatic breast cancer with PIK3CA mutation after progression on endocrine therapy. The FDA set a PDUFA goal date of June 25, 2027. This acceptance follows positive Phase 3 clinical trial data and builds on REVTORPYK's prior FDA approval for patients without the PIK3CA mutation. If approved, the drug could expand treatment options for a broader patient group with this common breast cancer subtype.

Celcuity's FDA acceptance of the sNDA for REVTORPYK provides context for health sector investors. For readers following health stocks, here is Pluang's market snapshot as of Nov 09, 2026 19:41 WIB: out of 150 priced US health-sector stocks tradable on Pluang, 121 rose and 18 fell today. Notable movers include INO (Inovio Pharmaceuticals Inc) at USD 1.32 with a 1-day change of +8.64% and a typical hold time of 41 days, FLNA (Cassava Sciences Inc) at USD 0.48 with +5.94% change and a 39-day hold time, and LFST (LifeStance Health Group Inc.) at USD 12.99 with -5.66% change and a 12-day hold time.

More News

New nonprofit Software Safety Institute launches to reduce harm from insecure software.

New nonprofit Software Safety Institute launches to reduce harm from insecure software.

The Software Safety Institute (SSI), a new independent nonprofit, has launched to tackle preventable harm caused by unsafe and insecure software. SSI aims to improve software safety by changing industry incentives and practices through research, publ...

Market News
Neutral
1 hour ago
Silvercrest ranks #8 in Nasdaq eVestment Q3 2026 Brand Awareness among mid-sized asset managers

Silvercrest ranks #8 in Nasdaq eVestment Q3 2026 Brand Awareness among mid-sized asset managers

Silvercrest Asset Management Group Inc. was ranked #8 in Nasdaq eVestment’s Q3 2026 Brand Awareness Rankings among mid-sized firms managing $2.5 billion to $40 billion in assets. This ranking reflects strong engagement from consultants and asset owne...

Market News
Bullish
1 hour ago
AST SpaceMobile to report Q3 earnings amid satellite network expansion and new Japan joint venture

AST SpaceMobile to report Q3 earnings amid satellite network expansion and new Japan joint venture

AST SpaceMobile is set to report its Q3 2026 earnings with an expected loss of $0.42 per share and revenue of $45.7 million. The company is advancing its satellite network technology, including a new joint venture with Rakuten to build a direct-to-de...

Company Fundamentals
Neutral
2 hours ago
AnorTech closes $7.55M share exchange, Greenland Mines now owns 19.9% stake

AnorTech closes $7.55M share exchange, Greenland Mines now owns 19.9% stake

AnorTech Inc. completed a $7.55 million share exchange with Nasdaq-listed Greenland Mines, increasing Greenland Mines' ownership in AnorTech to 19.9%. Greenland Mines acquired over 25 million AnorTech shares in exchange for Greenland Mines shares val...

Company Fundamentals
Bullish
2 hours ago
Neo launches Neoverse, a free AI security engine analyzing 4M+ AI apps to block malicious software automatically.

Neo launches Neoverse, a free AI security engine analyzing 4M+ AI apps to block malicious software automatically.

Neo Security, Inc. has launched Neoverse, a free AI software intelligence engine that researches and classifies over 4 million AI apps, extensions, and servers to assess their capabilities and security risks. Integrated into Neo's platform, Neoverse ...

Others
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App